Research Article
Role of Tumor Associated Fibroblasts in Human Liver Regeneration, Cirrhosis, and Cancer
Table 2
Surface immunophenotype of N-, C-, and L-MASCs. Bonferroni post test: *
C- versus L-MASCs; **
N- versus L-MASCs.
| | | MASCs | | P | | N | C | L |
| CD49b | 99.3 ± 1.6 | 98.4 ± 4.1 | 84 ± 14 | 0,0008*, ** | CD13 | 98.6 ± 2.8 | 97.8 ± 5.4 | 97 ± 7 | n.s. | CD73 | 97 ± 5.7 | 98.3 ± 2.9 | 93 ± 10 | n.s. | CD44 | 90 ± 21.84 | 92.2 ± 14.5 | 91 ± 17 | n.s. | CD90 | 90.6 ± 16.4 | 92.2 ± 19.5 | 79 ± 20 | n.s. | CD59 | 89.2 ± 23.8 | 98.2 ± 4.1 | 82 ± 9 | n.s. | CD29 | 88.5 ± 15.4 | 91.1 ± 19.4 | 79 ± 15 | n.s. | CD49a | 86 ± 33.3 | 89 ± 10.3 | 70 ± 9 | n.s. | CD105 | 84.6 ± 12.9 | 86.3 ± 21.5 | 75 ± 16 | n.s. | CD49d | 54.9 ± 43.7 | 46.2 ± 31.6 | 98 ± 2 | 0.008* | E-cadherin | 4.39 ± 7.5 | 3.75 ± 9 | n.d. | | CD10 | 37.7 ± 28.8 | 31.1 ± 33.4 | 8.2 ± 10.9 | n.s. | N-cadherin | 2.56 ± 5.3 | 2.15 ± 5.1 | n.d. | | CD66e | 0.41 ± 0.58 | 0.24 ± 0.51 | 1.4 ± 1.7 | n.s. | CD271 | 0.22 ± 0.20 | 0.39 ± 0.65 | 0.52 ± 0.16 | n.s. | CD45 | 0.19 ± 0.26 | 0.16 ± 0.35 | 0.05 ± 0.04 | n.s. | ABCG2 | 0.18 ± 0.10 | 0.24 ± 0.2 | 0.21 ± 0.12 | n.s. | CD117 | 0.17 ± 0.23 | 0.11 ± 0.15 | 0.03 ± 0.05 | n.s. | CD133 | 0.17 ± 0.19 | 0.23 ± 0.27 | 0.18 ± 0.24 | n.s. | CD34 | 0.11 ± 0.10 | 0.10 ± 0.18 | 0.03 ± 0.05 | n.s. |
|
|